Amanda Nizam, MD (@amandanizammd) 's Twitter Profile
Amanda Nizam, MD

@amandanizammd

GU Medical Oncologist @ClevelandClinic | Bladder, kidney, & prostate Ca | Tx-related toxicity | @ASCOTECAG & @GWSMHS alum | 🌎 citizen | Views my own | COI ⬇️

ID: 106342723

linkhttps://coi.asco.org/share/VF7-WR44/Amanda%20Nizam calendar_today19-01-2010 07:22:54

4,4K Tweet

1,1K Followers

1,1K Following

European Urology (@euplatinum) 's Twitter Profile Photo

📘 Just published in European Urology: 🔄 The 2025 EAU Guidelines on UTUC are here! 🧬 Major updates include: • Revised risk stratification framework • New recommendations for kidney-sparing approaches in low-risk UTUC • Clarified indications for perioperative chemotherapy &

📘 Just published in European Urology:

🔄 The 2025 EAU Guidelines on UTUC are here!

🧬 Major updates include:
• Revised risk stratification framework
• New recommendations for kidney-sparing approaches in low-risk UTUC
• Clarified indications for perioperative chemotherapy &
Larry Sabato (@larrysabato) 's Twitter Profile Photo

President Jim Ryan’s resignation letter to UVA community. Note that he didn’t stay and fight because the Trump Administration would have cut UVA’s federal funding drastically, cutting hundreds of jobs, financial aid for students, even visas for international students.

President Jim Ryan’s resignation letter to <a href="/UVA/">UVA</a> community. Note that he didn’t stay and fight because the Trump Administration would have cut UVA’s federal funding drastically, cutting hundreds of jobs, financial aid for students, even visas for international students.
Niklas KlĂźmper (@niklas_kluemper) 's Twitter Profile Photo

Great data and very important for the tumor agnostic T-DXd approval in HER2 3+! For GU Oncology: In this large dataset only 13.9% of UC are HER2 3+ and would thus qualify for T-DXd, which demonstrated ORR of 56% in pretreated mUC in the DESTINY-PanTumor02 Trial ASCO Uromigos

Rahul Banerjee, MD, FACP (@rahulbanerjeemd) 's Twitter Profile Photo

👏 I saw an interesting anecdote and just looked up the reference. Literally before I was born, an oncologist very succinctly and elegantly summarized how we offer hope to our patients living with cancer... these words are still true today! pubmed.ncbi.nlm.nih.gov/18750361/

👏 I saw an interesting anecdote and just looked up the reference.

Literally before I was born, an oncologist very succinctly and elegantly summarized how we offer hope to our patients living with cancer... these words are still true today!

pubmed.ncbi.nlm.nih.gov/18750361/
Adam S. Minsky (@adamsminsky) 's Twitter Profile Photo

Senate Republicans made some notable changes to the student loan provisions of the megabill that they voted to advance last night. Here's a side-by-side breakdown of the tweaks. Some are fairly significant. forbes.com/sites/adammins…

Jonathan Reiner (@jreinermd) 's Twitter Profile Photo

America’s docs, time to get off the sidelines and tell your members of congress what it will mean to your patients if 14 million people in this country lose their health insurance.

ProPublica (@propublica) 's Twitter Profile Photo

We previously reported on how a DOGE staffer with no government or health care experience created an AI tool to mark VA contracts as “munchable.” Among the contracts it canceled: critical projects to help improve cancer treatment and nursing care. propublica.org/article/doge-v…

Ana I. VelĂĄzquez MaĂąana, MD, MSc, FASCO (@anavmanana) 's Twitter Profile Photo

Devastating. The deliberate effort to crush publicly funded science and innovation in this country, captured in a single table. Our education, science, and innovation are the foundation of America’s global leadership. If we’re serious about creating American jobs, pushing to

ACS Journal Cancer (@journalcancer) 's Twitter Profile Photo

New editorial led by Robin Yabroff comments on a recent report finding that up-to-date colorectal cancer screening increased most in Medicaid expansion states w/ paid leave laws relative to nonexpansion states w/o paid leave laws. acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… OncoAlert

New editorial led by <a href="/DrRobinYabroff/">Robin Yabroff</a> comments on a recent report finding that up-to-date colorectal cancer screening increased most in Medicaid expansion states w/ paid leave laws relative to nonexpansion states w/o paid leave laws. 

acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn…

<a href="/OncoAlert/">OncoAlert</a>
Jason Westin, MD FACP FASCO (@lymphoma_doc) 's Twitter Profile Photo

We have life saving cancer drugs and life threatening shortages. ⁦Julie Gralow⁩, ASCO⁩ staff, and I discuss why, and potential solutions in ⁦JCO Oncology Practice⁩: ascopubs.org/doi/10.1200/OP…

Jonathan Lemire (@jonlemire) 's Twitter Profile Photo

“Congress is about to impose immense harm on tens of millions of Americans—taking away their health insurance, reducing welfare benefits, raising energy costs, and more—in order to benefit a handful of other Americans who least need the help” theatlantic.com/politics/archi…

Paolo Tarantino (@ptarantinomd) 's Twitter Profile Photo

First positive phase 3 trial for a bispecific ADC (EGFR/HER3 topo1 ADC), co-developed by BiokinPharma & BMS. Bispecific ADCs are coming! fiercebiotech.com/biotech/biokin…

Pavlos Msaouel (@pavlosmsaouel) 's Twitter Profile Photo

🚀 Now enrolling MD Anderson Cancer Center: IVORY trial of #ivonescimab (first-in-class PD1×VEGF bispecific) in metastatic clear cell #KidneyCancer after prior IO±TKI. Hypothesis: cooperative inhibition of PD1/VEGF signaling will restore treatment sensitivity 👉 clinicaltrials.gov/study/NCT06940…

🚀 Now enrolling <a href="/MDAndersonNews/">MD Anderson Cancer Center</a>: IVORY trial of #ivonescimab (first-in-class PD1×VEGF bispecific) in metastatic clear cell #KidneyCancer after prior IO±TKI. Hypothesis: cooperative inhibition of PD1/VEGF signaling will restore treatment sensitivity 👉 clinicaltrials.gov/study/NCT06940…
Adam S. Minsky (@adamsminsky) 's Twitter Profile Photo

The bill has passed the House, and now heads to President Trump who will sign tomorrow. Never before has Congress passed a law that would take away benefits and relief from current student loan borrowers and college-bound families on such a massive scale. forbes.com/sites/adammins…

Tatiana Prowell, MD (@tmprowell) 's Twitter Profile Photo

Are you registered to #Vote? Take a moment in honor of the #FourthOfJuly to vote.org/am-i-registere… to check whether you are registered or to register. Midterm elections are Nov 3, 2026. All 435 House seats & 33 Senate seats are up for grabs.

The Atlantic (@theatlantic) 's Twitter Profile Photo

“Despite our flawed instinct to take the path of least resistance,” writes Dr. Arthur Brooks of Cicero's great life lesson, “we will always be better served by choosing to do the right thing”: theatlantic.com/ideas/archive/…

Nazli Dizman (@nazlidizman) 's Twitter Profile Photo

🙋‍♀️Hello!! How's your schedule this fall? 🌟#WomenInOncology, save Sep 27-28 for #LEAD25! It's a fantastic opportunity for career development, networking with many inspiring and impactful women in oncology! 👉 bioascend.com/lead/ Dr. Julie Brahmer Ana I. Velázquez Mañana, MD, MSc, FASCO Dr. Catherine Lai

🙋‍♀️Hello!! How's your schedule this fall? 
🌟#WomenInOncology, save Sep 27-28 for #LEAD25!
It's a fantastic opportunity for career development, networking with many inspiring and impactful women in oncology!   
👉 bioascend.com/lead/
<a href="/JulieBrahmer/">Dr. Julie Brahmer</a> <a href="/AnaVManana/">Ana I. VelĂĄzquez MaĂąana, MD, MSc, FASCO</a> <a href="/KatieLaiMD_MPH/">Dr. Catherine Lai</a>
Charles Jiang MD, MPH (@charlesjiangmd) 's Twitter Profile Photo

Incredibly important reminder: medicine is hard, and academia is even harder. We set ourselves up for disappointment if we don’t normalize failure. Rejections in publications, grants, and opportunities are part of the journey — not the end.